479 related articles for article (PubMed ID: 27514667)
1. Gastric biomarkers: a global review.
Baniak N; Senger JL; Ahmed S; Kanthan SC; Kanthan R
World J Surg Oncol; 2016 Aug; 14(1):212. PubMed ID: 27514667
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.
Carlomagno N; Incollingo P; Tammaro V; Peluso G; Rupealta N; Chiacchio G; Sandoval Sotelo ML; Minieri G; Pisani A; Riccio E; Sabbatini M; Bracale UM; Calogero A; Dodaro CA; Santangelo M
Biomed Res Int; 2017; 2017():7869802. PubMed ID: 29094049
[TBL] [Abstract][Full Text] [Related]
3. Current and future biomarkers in gastric cancer.
Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
Durães C; Almeida GM; Seruca R; Oliveira C; Carneiro F
Virchows Arch; 2014 Mar; 464(3):367-78. PubMed ID: 24487788
[TBL] [Abstract][Full Text] [Related]
5. How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.
Kim C; Mulder K; Spratlin J
Oncologist; 2014 Oct; 19(10):1046-55. PubMed ID: 25142842
[TBL] [Abstract][Full Text] [Related]
6. Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.
Myer NM; Shitara K; Chung HC; Lordick F; Kelly RJ; Szabo Z; Cao ZA; Leong S; Ilson DH; Weichert W
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2023-2043. PubMed ID: 35551464
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of gastric cancer: Current topics and future perspective.
Matsuoka T; Yashiro M
World J Gastroenterol; 2018 Jul; 24(26):2818-2832. PubMed ID: 30018477
[TBL] [Abstract][Full Text] [Related]
8. Predictive biomarkers along gastric cancer pathogenetic pathways.
Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R
Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834
[TBL] [Abstract][Full Text] [Related]
9. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
De Mello RA; Castelo-Branco L; Castelo-Branco P; Pozza DH; Vermeulen L; Palacio S; Salzberg M; Lockhart AC
Am Soc Clin Oncol Educ Book; 2018 May; 38():249-261. PubMed ID: 30231398
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma.
Ishikawa E; Nakamura M; Shimada K; Tanaka T; Satou A; Kohno K; Sakakibara A; Furukawa K; Yamamura T; Miyahara R; Nakamura S; Kato S; Fujishiro M
J Gastroenterol; 2020 Jan; 55(1):39-50. PubMed ID: 31493237
[TBL] [Abstract][Full Text] [Related]
11. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
12. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
13. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs in Gastric Cancer: Potential Biomarkers and Therapeutic Targets.
Ouyang J; Long Z; Li G
Biomed Res Int; 2020; 2020():2790679. PubMed ID: 32685459
[TBL] [Abstract][Full Text] [Related]
15. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
Liu XH; Sun M; Nie FQ; Ge YB; Zhang EB; Yin DD; Kong R; Xia R; Lu KH; Li JH; De W; Wang KM; Wang ZX
Mol Cancer; 2014 Apr; 13():92. PubMed ID: 24775712
[TBL] [Abstract][Full Text] [Related]
16. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract][Full Text] [Related]
18. Incorporating molecular biomarkers into clinical practice for gastric cancer.
Nakamura S; Kanda M; Kodera Y
Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
[No Abstract] [Full Text] [Related]
19. Clinical and biological markers in gastric cancer: update and perspectives.
Cappellani A; Zanghi A; Di Vita M; Zanet E; Veroux P; Cacopardo B; Cavallaro A; Piccolo G; Lo Menzo E; Murabito P; Berretta M
Front Biosci (Schol Ed); 2010 Jan; 2(2):403-12. PubMed ID: 20036956
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial.
Kim MH; Zhang X; Jung M; Jung I; Park HS; Beom SH; Kim HS; Rha SY; Kim H; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung HC
Cancer Res Treat; 2019 Apr; 51(2):819-831. PubMed ID: 30282452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
